review · Metabolism Open
A systematic review and meta-analysis of fifteen studies covering 67,040 participants between 2008 and 2022 establishes that sexual dysfunction is widespread among diabetic patients. The pooled global prevalence was 61.4 percent, with significant variations observed across geographic regions, gender, and diabetes classifications. By location, the European region displayed the highest rate at 66.05 percent. Sexual dysfunction was also more frequent in men than in women, affecting 65.91 percent of male patients compared to 58.81 percent of female patients. In addition, individuals diagnosed with type 2 diabetes mellitus faced the highest risk, showing a prevalence of 71.03 percent. Because sexual dysfunction carries severe physical, emotional, and social consequences, these figures indicate a critical necessity for regular clinical screening and targeted therapeutic interventions for people living with diabetes.
Diabetes often leads to complications that compromise quality of life, therapy adherence, and relationships. Knowing that over six in ten diabetic adults experience sexual dysfunction highlights a substantial yet frequently neglected healthcare challenge. These findings underline the necessity for clinicians to incorporate systematic screening and accessible treatment pathways into routine diabetes management programmes.
The abstract does not indicate an application pathway.
AI-generated from the published abstract. Always read the original work before citing.
Background: Both men and women can have a wide range of physical, emotional, and sexual issues as a result of diabetes. One of them is sexual dysfunction, which has an effect on marital relationships as well as the effectiveness of therapy and can develop into a serious social and psychological condition. As a result, the purpose of this study was to identify the global prevalence of sexual dysfunction among diabetic patients. Methods: was calculated and an overall estimated analysis was performed. Subgroup analysis was done by study region and sample size. The pooled odds ratio was also computed. Results: The study was able to include 15 of the 654 publications that were evaluated since they met the criteria. 67,040 people participated in the survey in all. The pooled global prevalence of sexual dysfunction among diabetic patients was 61.4% (95% CI: 51.80, 70.99), I2 = 71.6%. The frequency of sexual dysfunction was highest in the European region (66.05%). For males, the prevalence of sexual dysfunction was 65.91%, while for females, it was 58.81%. Patients with type 2 diabetes mellitus were more likely (71.03%) to experience sexual dysfunction. Conclusion: Finally, sexual dysfunction was fairly common all across the world. There were variations in the prevalence of sexual dysfunction depending on the sex, type of diabetes, and location of the study participant. Our findings imply that screening and appropriate treatment are required for diabetes persons exhibiting sexual dysfunction.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.metop.2023.100247
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
